Literature DB >> 3753854

Amyloidosis presenting in the lower respiratory tract. Clinicopathologic, radiologic, immunohistochemical, and histochemical studies on 48 cases.

A N Hui, M N Koss, L Hochholzer, W D Wehunt.   

Abstract

We studied 48 cases of amyloidosis localized to the lower respiratory tract. Fourteen cases were classified as tracheobronchial amyloidosis. Twenty-eight cases showed solitary or multiple nodules, and six cases had a diffuse interstitial parenchymal pattern. Almost all patients with tracheobronchial and diffuse interstitial amyloidosis had respiratory symptoms (usually dyspnea), whereas most with nodular amyloidosis were asymptomatic. Nodular parenchymal and, less frequently, tracheobronchial amyloidosis had contiguous cellular infiltrates of plasma cells, lymphocytes, and giant cells. Immunohistochemical staining of specimens from 18 cases showed these plasma cells to be polytypic, except for two tracheobronchial lesions that had a disproportionate number of lambda light chain-bearing plasma cells. Permanganate oxidation of specimens from 19 cases showed patterns in keeping with immunoglobulin-derived amyloid in 12. Local deposits of amyloid in lung may arise from deposition of circulating precursor proteins.

Entities:  

Mesh:

Year:  1986        PMID: 3753854

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  26 in total

Review 1.  Amyloidosis and the respiratory tract.

Authors:  J D Gillmore; P N Hawkins
Journal:  Thorax       Date:  1999-05       Impact factor: 9.139

2.  Nodular pulmonary amyloidosis occurring in association with pulmonary lymphoma.

Authors:  C J Davis; E G Butchart; A R Gibbs
Journal:  Thorax       Date:  1991-03       Impact factor: 9.139

3.  Diffuse interstitial lung disease due to AA amyloidosis.

Authors:  C Planes; D Kleinknecht; M Brauner; J P Battesti; J L Kemeny; D Valeyre
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

4.  Pulmonary nodules due to reactive systemic amyloidosis (AA) in Crohn's disease.

Authors:  T W Beer; C W Edwards
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

5.  An overview of monoclonal gammapathies.

Authors:  T Malati
Journal:  Indian J Clin Biochem       Date:  2001-01

6.  Localized nodular amyloidosis of the lung.

Authors:  Takashi Eguchi; Kazuo Yoshida; Nobutaka Kobayashi; Gaku Saito; Kazutoshi Hamanaka; Takayuki Shiina; Makoto Kurai; Maki Endo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-10-08

7.  Risk factors for recurrence of laryngeal amyloidosis treated by microforceps and CO2 laser.

Authors:  Xiufa Wu; Jing Zhang; Chunsheng Wei
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-11-19       Impact factor: 2.503

8.  Endoscopic management of laryngo-tracheobronchial amyloidosis: a series of 32 patients.

Authors:  Cesare Piazza; Sergio Cavaliere; Piero Foccoli; Carlo Toninelli; Andrea Bolzoni; Giorgio Peretti
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-02-26       Impact factor: 2.503

9.  Mimicking pulmonary multiple metastatic tumors: A case of primary nodular parenchymal pulmonary amyloidosis with review of the literature.

Authors:  Li-Na Zhang; Xin-Ying Xue; Na Wang; Jian-Xin Wang
Journal:  Oncol Lett       Date:  2012-09-20       Impact factor: 2.967

10.  Immunohistochemical characterization of amyloid proteins in sural nerves and clinical associations in amyloid neuropathy.

Authors:  K Li; R A Kyle; P J Dyck
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.